A Phase II Study of Neoadjuvant FOLFIRINOX

Clinical trial NCT02178709 · COMPLETED

Trial details

NCT number: NCT02178709
Sponsor: Indiana University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Pancreatic Ductal Adenocarcinoma

Start date: 2014-06-03
Primary completion: 2018-02-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.